CAS 206275-15-2

Fórmula: C26H22BrN5O2

InChI: InChI=1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34)

Clave InChI: SHNBLWMBWXIKMR-UHFFFAOYSA-N

SMILES: CC1=NC2=C(C=C(C(=C2)Br)CN(CC#C)C3=CC=C(C=C3)C(=O)NCC4=CN=CC=C4)C(=O)N1

Cb-30865

CAS: 206275-15-2

Cb-30865

Fórmula: C₂₆H₂₂BrN₅O₂

Pureza: 99.04%

Peso molecular: 516.39

Ref: 54-OR1133891

CB-30865

CAS: 206275-15-2

Fórmula: C₂₆H₂₂BrN₅O₂

Pureza: 98.05%

Peso molecular: 516.3892

Ref: IN-DA002IEH

CB30865

CAS: 206275-15-2

CB30865 is a proliferation inhibitor that has been shown to be effective in the treatment of cancer. It has been shown to inhibit cell growth and induce cell death in vitro and in vivo. CB30865 binds to a cellular target that is not yet identified, which may be due to its chemical structure. This drug has been shown to have no effect on healthy cells, making it an ideal candidate for the treatment of cancer. It also has potential uses as a diagnostic agent for inflammatory diseases or other diseases with specific targets.

Fórmula: C₂₆H₂₂BrN₅O₂

Pureza: Min. 95%

Peso molecular: 516.39 g/mol

Ref: 3D-GIA27515

CB30865

CAS: 206275-15-2

CB30865 (ZM 242421) is a selective and highly effective nicotinamide phosphoribosyltransferase (Nampt) inhibitor with potential antitumor activity.

Fórmula: C₂₆H₂₂BrN₅O₂

Pureza: 99.04%

Forma y color: Solid

Peso molecular: 516.389

Ref: TM-T14882